These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34683871)

  • 1. Population Pharmacokinetic Modelling of the Complex Release Kinetics of Octreotide LAR: Defining Sub-Populations by Cluster Analysis.
    Kapralos I; Dokoumetzidis A
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR.
    Comets E; Mentré F; Nimmerfall F; Kawai R; Mueller I; Marbach P; Vonderscher J
    J Control Release; 1999 May; 59(2):197-205. PubMed ID: 10332054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide.
    Petersen H; Bizec JC; Schuetz H; Delporte ML
    BMC Res Notes; 2011 Sep; 4():344. PubMed ID: 21906300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects.
    Zhou H; Chen TL; Marino M; Lau H; Miller T; Kalafsky G; McLeod JF
    Br J Clin Pharmacol; 2000 Dec; 50(6):543-52. PubMed ID: 11136293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic analysis for hydrocodone following the administration of hydrocodone bitartrate extended-release capsules.
    Melhem MR; Rubino CM; Farr SJ; Robinson CY
    Clin Pharmacokinet; 2013 Oct; 52(10):907-17. PubMed ID: 23719682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.
    Comets E; Mentré F; Kawai R; Nimmerfall F; Marbach P; Vonderscher J
    J Pharm Sci; 2000 Sep; 89(9):1123-33. PubMed ID: 10944377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors.
    Jung SY; Yug JS; Clarke JM; Bauer TM; Keedy VL; Hwang S; Kim SJ; Chung EK; Lee JI
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):173-183. PubMed ID: 31673825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
    Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.
    Yang S; Lukey P; Beerahee M; Hoke F
    Clin Pharmacokinet; 2013 Mar; 52(3):187-98. PubMed ID: 23254770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic modelling of tramadol using inverse Gaussian function for the assessment of drug absorption from prolonged and immediate release formulations.
    Brvar N; Mateović-Rojnik T; Grabnar I
    Int J Pharm; 2014 Oct; 473(1-2):170-8. PubMed ID: 25014367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
    Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
    Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
    Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.
    Higuchi K; Yamashita D; Kashihara Y; Kakara M; Hirota T; Hirakawa M; Ieiri I
    Ther Drug Monit; 2019 Oct; 41(5):674-680. PubMed ID: 31095070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
    Olsson Gisleskog PO; Perez Ruixo JJ; Westin Å; Hansson AC; Soons PA
    Clin Pharmacokinet; 2021 Apr; 60(4):541-561. PubMed ID: 33354734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
    Zhao W; Cella M; Della Pasqua O; Burger D; Jacqz-Aigrain E;
    Br J Clin Pharmacol; 2012 Apr; 73(4):641-50. PubMed ID: 21988586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults.
    Choi S; Jeon S; Han S
    Transl Clin Pharmacol; 2018 Mar; 26(1):25-31. PubMed ID: 32055544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetic Analysis of Tiropramide in Healthy Korean Subjects.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32325672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
    Wang D; Lu J; Li Q; Li Z
    Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.